Research Profile of Dropoetin 2000IU
Dropoetin 2000IU is a recombinant human erythropoietin (rHuEPO) preparation designed for advanced laboratory research applications. This pharmaceutical-grade compound from DROGSAN represents a sophisticated glycoprotein hormone analogue extensively investigated for its role in erythropoiesis regulation and cellular metabolism studies. Researchers at Stroid UK Shop utilise this preparation to examine haematopoietic pathways, hypoxia-inducible factor responses, and bone marrow stem cell differentiation mechanisms in controlled laboratory environments.
Scientific Applications
Contemporary research protocols evaluate Dropoetin’s capacity to stimulate erythroid progenitor proliferation through erythropoietin receptor (EPOR) activation cascades. Laboratory investigations focus on JAK2/STAT5 signalling pathway modulation, demonstrating how recombinant erythropoietin influences cellular survival, differentiation, and haemoglobin synthesis in experimental models. Researchers examining erythropoietin compounds analyse tissue-protective mechanisms beyond haematopoiesis, including neuroprotective properties and angiogenic responses in various cell culture systems. Studies investigate dose-response relationships, pharmacokinetic profiles, and comparative efficacy against endogenous erythropoietin in standardised assays. Advanced research programmes examine potential applications in regenerative medicine protocols, utilising this compound alongside selective receptor modulators to understand tissue repair mechanisms. Investigations also encompass combination studies with research peptides to evaluate synergistic effects on cellular metabolism and growth factor expression patterns.
Technical Specifications
| Parameter | Specification |
|---|---|
| Biological Activity | 2000 International Units |
| Protein Type | Recombinant Human Erythropoietin |
| Molecular Weight | Approximately 30.4 kDa |
| Storage Temperature | 2-8°C (refrigerated) |
| Stability | Verify with supplier documentation |
| Research Grade | Pharmaceutical Standard |
Laboratory Compliance
This Dropoetin 2000IU preparation is manufactured exclusively for in-vitro research applications and laboratory analysis protocols. Not approved for human therapeutic use, clinical administration, or any form of personal consumption. Researchers must maintain appropriate biosafety protocols, proper storage conditions, and institutional oversight when conducting erythropoietin-related investigations in certified laboratory facilities.
